Aveiro-Lavrador Mariana, De Sousa Lages Adriana, Barros Luísa, Paiva Isabel
Endocrinology, Diabetes and Metabolism Department, Coimbra Hospital and University Center, Coimbra, Portugal.
Endocrinology Department, Braga Hospital, Braga, Portugal.
Endocrinol Diabetes Metab Case Rep. 2021 May 1;2021. doi: 10.1530/EDM-21-0032.
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders related to enzyme deficiencies in the adrenal steroidogenesis pathway leading to impaired corticosteroid biosynthesis. Depending on the extension of enzyme defect, there may be variable severities of CAH - classic and non-classic. We report the case of a 37-year-old male patient with a previously unknown diagnosis of classic CAH referred to Endocrinology evaluation due to class III obesity and insulin resistance. A high diagnostic suspicion was raised at the first Endocrinology consultation after careful past medical history analysis especially related to the presence of bilateral adrenal myelolipomas and primary infertility. A genetic test confirmed the presence of a variant of the CYP21A2 in homozygous with an enzymatic activity of 0-1%, corresponding to a classic and severe CAH form. Our case represents an unusually late definitive diagnose of classic CAH since the definition was established only during adulthood in the fourth decade of life. The missing diagnosis of classic 21 hydroxylase deficiency during infancy led to important morbidity, with a high impact on patients' quality of life.
Congenital adrenal hyperplasia (CAH) refers to a group of autosomal recessive enzyme disorders responsible for an impaired cortical adrenal hormonal synthesis. CAH may be divided into two major forms: classic and non-classic CAH. If untreated, CAH may be fatal or may be responsible for important multi-organ long-term consequences that can be undervalued during adulthood. Adrenal myelolipomas are associated with chronic exposure to high ACTH levels and continuous androgen hyperstimulation typically found in undertreated CAH patients. Testicular adrenal rest tumours (TART) and primary infertility can be the first manifestation of the disease during adulthood.
先天性肾上腺皮质增生症(CAH)是一组常染色体隐性疾病,与肾上腺类固醇生成途径中的酶缺陷有关,导致皮质类固醇生物合成受损。根据酶缺陷的程度,CAH可能有不同的严重程度——典型型和非典型型。我们报告了一例37岁男性患者,因III级肥胖和胰岛素抵抗转诊至内分泌科评估,此前未被诊断出患有典型CAH。在内分泌科首次会诊时,通过仔细分析既往病史,尤其是双侧肾上腺髓质脂肪瘤的存在和原发性不育症,高度怀疑为CAH。基因检测证实存在纯合子CYP21A2变体,酶活性为0 - 1%,对应典型且严重的CAH类型。我们的病例代表了典型CAH异常晚的确诊,因为确诊是在成年期第四个十年才得以确定。婴儿期未诊断出典型的21羟化酶缺乏症导致了严重的发病率,对患者生活质量产生了重大影响。
先天性肾上腺皮质增生症(CAH)是指一组常染色体隐性酶疾病,导致肾上腺皮质激素合成受损。CAH可分为两种主要类型:典型型和非典型型CAH。如果不治疗,CAH可能是致命的,或者可能导致重要的多器官长期后果,而这些后果在成年期可能被低估。肾上腺髓质脂肪瘤与长期暴露于高水平促肾上腺皮质激素(ACTH)以及未得到充分治疗的CAH患者中常见的持续雄激素过度刺激有关。睾丸肾上腺残余肿瘤(TART)和原发性不育可能是该疾病在成年期的首发表现。